p21WAF1/CIP1 gene DNA sequencing and its expression in human osteosarcoma

Chinese Medical Journal

Volumn 117, Issue 6, 2004, Pages 936-940

  Liao, Wei Ming ^a   Zhang, Chun Lin ^b   Li, Fo Bao ^a   Zeng, Bing Fang ^b   Zeng, Yi Xin ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

DNA sequencing; Geneexpression; Osteosarcoma; p21WAF1 CIP1 gene; PCR SSCP

Indexed keywords

MESSENGER RNA; PROTEIN P21; CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLINE;

ARTICLE; BLOOD SAMPLING; CANCER PATIENT; CHINESE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; DNA SEQUENCE; EXON; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; OSTEOSARCOMA; PHENOTYPE; POLYMERASE CHAIN REACTION; PROGNOSIS; SILVER STAINING; SINGLE STRAND CONFORMATION POLYMORPHISM; GENETICS;

CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; HUMANS; OSTEOSARCOMA; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RNA, MESSENGER; SEQUENCE ANALYSIS, DNA;

EID: 3242711320     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. El-Deiry WS, Tokino T, Velculescu VE, et al. WAF1, a potential mediator of p53 tumor suppression. Cell 1993;75: 817-825.
2. Harper JW, Adami GR, Wei N, et al. The p21 cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 1993;75:805-816.
3. Wilczynski SP, Bergen S, Walker J, et al. Human papillomaviruses and cervical cancer: analysis of histopathologic features associated with different viral types. Human Pathol 1988;19:697-704.
4. Su HC. In situ hybrization. Beijing: Chinese Sciences and Technology Publishing House;1994: 59-65.
5. Hayashi K. PCR-SSCP: a simple and sensitive method for detection of mutations in the genomic DNA. PCR Methods Appl 1991;1:34-38.
6. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. Cold Spring Harbor: Cold Spring Harbor Laboratory; 1989:17-86.
7. Pagano M, Pepperkok R, Lukas J, et al. Regulation of the human cell cycle by the cdk2 protein kinase in cultured human fibroblasts. J Cell Biol 1993;121:101-111.
8. Fang F, Newport JW. Evidence that the G1-S and G2-M transitions are controlled by different cdc2 proteins in higher eukaryotes. Cell 1991;66:731-742.
9. Keyomarsi K, Pardee AB. Redundant cyclin overexpression and gene amplitication in breast cancer cells. Proc Natl Acad Sci U S A 1993;90:1112-1116.
10. Leach FS, Elledge SJ, Sherr CJ, et al. Amplification of cyclin genes in colorectal carcinomas. Cancer Res 1993;53: 1986-1989.
11. Sherr CJ. Mammalian G1 cyclins. Cell 1993;73:1059-1065.
12. Xiong Y, Hannon GJ, Zhang H, et al. p21 is a universal inhibitor of cyclin kinases. Nature 1993;366:701-704.
13. Xiong Y, Zhang H, Beach D. Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation. Genes Dev 1993;7:1572-1583.
14. El-Deiry WS, Harper JW, O'Connor PM, et al. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 1994;54:1169-1174.
15. Ramirez PT, Gershenson DM, Tortolero-Luna G. Expression of cell-cycle mediators in ovarian cancer cells after transfection with p16 (INK4a), p21 (WAF1/Cip-1 and p53. Gynecol Oncol 2001;83:543-548.
16. Winters ZE, Hunt NC, Bradburn MJ. Subcellular localisation of cyclin B, Cdc2 and p21 (WAF1/CIP1) in breast cancer: association with prognosis. Eur J Cancer 2001; 37: 2405-2412.
17. WAF1/CIP1 on the malignant phenotype and apoptosis of human hepatocellular carcinoma cells. Chin J Cancer (Chin) 1999; 21:99-101.
18. Baldus SE, Schneider PM, Monig SP. p21/waf1/cip1 in gastric cancer: associations with histopathological subtypes, lymphonodal metastasis, prognosis and p53 status. Scand J Gastroenterol 2001;36:975-980.
19. Morita R, Ishikawa J, Tsutsumi M, et al. Allelotype of renal cell carcinoma. Cancer Res 1991;51:820-823.
20. Vogelstein B, Fearon ER, Kern SE, et al. Allelotype of colorectal carcinomas. Science 1989;244:207-211.
21. Sato T, Saito H, Morita R, et al. Allelotype of human ovarian cancer. Cancer Res 1991;51:5118-5122.
22. Shiohaia M, el-Deiry WS, Wada M, et al. Absence of WAF1 mutation in a variety of human malignancies. Blood 1994;84: 3781-3784.
23. WAF1/CIP1 cyclin-dependent kinase inhibitor Gene. Cancer 1997;79:2424-2429.
24. Chedid M, Michieli P, Lengel C, et al. A single nucleotide substitution at condon 31 (Ser/Arg) defines a polymorphism in a highly conserved region of the p53-inducible gene WAF1/CIP1. Oncogene 1994;9:3021-3024.
25. Leach FS, Elledge SJ, Sherr CJ, et al. Amplification of cyclin genes in colorectal carcinomas. Cancer Res 1993;53: 1986-1989.
26. Hinds PW, Dowdy SF, Eaton EN, et al. Function of a human cyclin gene as an oncogene. Proc Natl Acad Sci U S A 1994;91:709-713.